494850-87-2 Usage
Molecular Structure
1H-Pyrrole-1-ethanol, 2-methyl-5-[4-(methylthio)phenyl]-, methanesulfonate (ester) has a complex structure that includes a pyrrole ring and an ethanol group.
Substituent
The compound contains a 2-methyl-5-[4-(methylthio)phenyl] substituent.
Functional Group
The compound has a methanesulfonate ester group.
Reactivity
The presence of the methanesulfonate ester group makes 1H-Pyrrole-1-ethanol, 2-methyl-5-[4-(methylthio)phenyl]-,methanesulfonate (ester) highly reactive in organic reactions.
Uses
1H-Pyrrole-1-ethanol, 2-methyl-5-[4-(methylthio)phenyl]-, methanesulfonate (ester) is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals, agrochemicals, and materials.
Importance in Medicinal Chemistry
The compound has several potential applications in medicinal chemistry and drug development due to its unique structure and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 494850-87-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,4,8,5 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 494850-87:
(8*4)+(7*9)+(6*4)+(5*8)+(4*5)+(3*0)+(2*8)+(1*7)=202
202 % 10 = 2
So 494850-87-2 is a valid CAS Registry Number.
494850-87-2Relevant academic research and scientific papers
AN IMPROVED PROCESS FOR THE PREPARATION OF PYRROLE DERIVATIVES
-
, (2015/03/28)
The present invention relates to an improved process for the preparation of pyrroles derivatives having hypolipidemic and hypocholesteremic activities. In particular, the invention relates to an improved process for the preparation of 2- ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy) phenyl)propanoate and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also relates to an improved process for the preparation of mesylate compound (A1).
A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES
-
Page/Page column 30; 31, (2015/01/06)
The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
